Immunovant, Inc. (IMVT)
23.56
+0.80
(+3.51%)
USD |
NASDAQ |
Dec 10, 16:00
22.22
-1.34
(-5.69%)
Pre-Market: 08:00
Immunovant EPS Diluted (Quarterly): -0.7285 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revvity, Inc. | 0.4066 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.50M |
| Total Expenses (Quarterly) | 126.50M |
| Enterprise Value | 3.608B |
| Earnings Yield | -12.01% |
| Normalized Earnings Yield | -12.01 |